|
Wednesday, May 16, 2018, Washington, DC, 6:00 PM – 8:30 PM
Oncology Grand Rounds: Nurse and Physician Investigators Discuss New Agents, Novel Therapies and Actual Cases from Practice — A CNE Symposia Series Held During the 43rd Annual ONS CongressPART 1 — Lymphoma and Chronic Lymphocytic Leukemia
Location:
Marriott Marquis Washington, DC 901 Massachusetts Ave NW Washington, DC 20001 Hotel Phone: (202) 824-9200 Meeting Room: Independence A-E (Meeting Level 4)
Schedule (EST):
5:30 PM – 6:00 PM Registration and Dinner Buffet 6:00 PM – 8:30 PM Educational Program
Faculty:
Ethan M Basch, MD, MSc Professor of Medicine and Public Health Director, Cancer Outcomes Research Program Co-Leader, Cancer Prevention and Control Associate Chief, Division of Oncology University of North Carolina at Chapel Hill Chapel Hill, North Carolina Andrew M Evens, DO, MSc Associate Director for Clinical Services Rutgers Cancer Institute of New Jersey Medical Director, Oncology Service Line RWJBarnabas Health Director, Lymphoma Program Division of Blood Disorders Professor of Medicine Rutgers Robert Wood Johnson Medical School New Brunswick, New Jersey
Amy Goodrich, CRNP-AC
Nurse Practitioner Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland Robin Klebig, APRN, CNP, AOCNP Division of Hematology, Lymphoma Group Mayo Clinic Rochester, Minnesota Mitchell R Smith, MD, PhD Professor of Medicine Associate Center Director for Clinical Investigations Division of Hematology and Oncology GW Cancer Center Washington, DC Moderator: Neil Love, MD Research To Practice Miami, Florida Module 1: Chronic Lymphocytic Leukemia (CLL) DISCUSSION TOPICS
Module 2: Hodgkin Lymphoma (HL) DISCUSSION TOPICS
Module 3: Follicular Lymphoma (FL) DISCUSSION TOPICS
Module 4: Diffuse Large B-Cell Lymphoma (DLBCL) DISCUSSION TOPICS
Module 5: Mantle Cell Lymphoma (MCL) DISCUSSION TOPICS
Module 6: T-Cell Lymphoma (TCL) DISCUSSION TOPICS
Special Session: Dr Basch Using innovative communication strategies to assist nurses and other caregivers in meeting the needs of patients with cancer Target Audience:
Research To Practice (RTP) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s (ANCC) Commission on Accreditation. Credit Designation Statements: This educational activity for 2.5 contact hours is provided by RTP. This activity is awarded 2.5 ANCC pharmacotherapeutic contact hours. To obtain a certificate of completion and receive credit for this event, nurses must sign in at the registration desk upon arrival, attend the entire activity and return a completed Educational Assessment and Credit Form upon exiting the activity. Oncology Nursing Certification Corporation (ONCC)/Individual Learning Needs Assessment (ILNA) Certification Information: The program content has been reviewed by the ONCC and is acceptable for recertification points. Learners must apply for CNE credit to utilize this program for ONCC certification or renewal. http://www.ResearchToPractice.com/Meetings/ONS2018/ILNA Unlabeled/Unapproved Uses Notice: There is no implied or real endorsement of any product by RTP or the ANCC. Any off-label use as declared by the FDA will be identified. Content Validation and Disclosures: RTP is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess conflicts of interest with faculty, planners and managers of CNE activities. Conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the RTP scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations. RTP staff and external reviewers — The scientific staff, planners and managers for RTP have no relevant conflicts of interest to disclose. Supporters: This activity is supported by educational grants from AbbVie Inc, Acerta Pharma — A member of the AstraZeneca Group, Bayer HealthCare Pharmaceuticals, Celgene Corporation, Janssen Biotech Inc, administered by Janssen Scientific Affairs LLC, Pharmacyclics LLC, an AbbVie Company, and Seattle Genetics. Marriott Marquis Washington, DC Meeting Room: The Marriott Marquis Washington, DC is the headquarters hotel for the 2018 ONS Congress and provides direct access to the Walter E Washington Convention Center via an underground concourse.
Thank you for your interest in our CNE symposia series. At this time, online preregistration is closed for PART 1 — Lymphoma and Chronic Lymphocytic Leukemia. Onsite registration will be open starting at 5:15 PM (ET) on Wednesday, May 16th. If you are interested in standing by for seating (day of the program), please visit our onsite registration desk located outside Independence A-E, Ballroom (Meeting Level 4) at the Marriott Marquis Washington, DC (901 Massachusetts Ave NW, Washington, DC 20001). You may arrive up to 45 minutes before the program start time and receive a standby ticket. If seats become available for the program, we will accept standby registration on a first come, first served basis. Please note, onsite registration does not guarantee participation in the session or meal service. If you have any questions, please feel free to contact us via email at Meetings@ResearchToPractice.com or call (800) 233-6153. |